Loring Wolcott & Coolidge Fiduciary Advisors’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-384
Closed -$11K 711
2021
Q4
$11K Hold
384
﹤0.01% 591
2021
Q3
$10K Hold
384
﹤0.01% 594
2021
Q2
$11K Buy
+384
New +$10.2K ﹤0.01% 622
2021
Q1
Sell
-384
Closed -$7K 654
2020
Q4
$7K Buy
+384
New +$6.91K ﹤0.01% 647

Other funds holding TBI

Loring Wolcott & Coolidge Fiduciary Advisors's TBI Position: Q1 2022 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Trueblue (TBI) in Q1 2022, closing a stake of 384 shares — an estimated $11K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in TBI in Q4 2020 and held it in 4 quarters. The position peaked at $11K in Q4 2021. 183 funds tracked by Wall St. Rank hold TBI as of Q1 2022.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Trueblue position as of Q1 2022 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 384 Trueblue shares in Q1 2022, an estimated $11K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Trueblue in Q4 2020 and held it in 4 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Trueblue position peaked at $11K in Q4 2021.
  • 183 funds tracked by Wall St. Rank held Trueblue as of Q1 2022.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2022, filed 13 Apr 2022.